Surrozen (SRZN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Surrozen (SRZN) is Neutral.

The composite score behind that read is -0.13, weighing +0.22 of bullish evidence against -0.26 bearish.

Surrozen last closed at $29.13, -0.65% on the session.

Against the IVW growth benchmark the position is -1.57% over the forecast window.

The read is built from 12 underlying insights — 4 bullish and 8 bearish.

Agreement across those insights is 67%.

15 graded predictions for SRZN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Surrozen in the 97th percentile on return on equity, where 100 is best.

Surrozen is classified under Health Care / Biotechnology, with a market capitalisation of $344.63M.

StockMap tracks Surrozen as the 189th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Surrozen ranks 99th of 344 in the group, against a group median of -0.21.